JPS6438023A - Unshakable specific drug for burn embrocation for external use - Google Patents

Unshakable specific drug for burn embrocation for external use

Info

Publication number
JPS6438023A
JPS6438023A JP61314570A JP31457086A JPS6438023A JP S6438023 A JPS6438023 A JP S6438023A JP 61314570 A JP61314570 A JP 61314570A JP 31457086 A JP31457086 A JP 31457086A JP S6438023 A JPS6438023 A JP S6438023A
Authority
JP
Japan
Prior art keywords
embrocation
unshakable
burn
glair
cinnabar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61314570A
Other languages
Japanese (ja)
Inventor
Masao Nakayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP61314570A priority Critical patent/JPS6438023A/en
Publication of JPS6438023A publication Critical patent/JPS6438023A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain an unshakable specific drug for burn embrocation for external use, leaving no scar after healing, useful for early recovery, by blending honey with cinnabar and hen's egg. CONSTITUTION:8.30mg, 33.2% honey, 0.55mg, 2.2% cinnabar and 16.15mg, 64.6% glair are used as components. In blending, powder cinnabar is added to honey and well blended. Further chalaza attached to the glair itself is removed and only the glair is well kneaded with the blend. In blending, materials to be used, including splittable chopsticks, etc., are thermally disinfected and used. The blend is kept at 2-4 deg.C and the effective period is two months. In use, use of other ointment is wholly forbidden.
JP61314570A 1986-12-23 1986-12-23 Unshakable specific drug for burn embrocation for external use Pending JPS6438023A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61314570A JPS6438023A (en) 1986-12-23 1986-12-23 Unshakable specific drug for burn embrocation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61314570A JPS6438023A (en) 1986-12-23 1986-12-23 Unshakable specific drug for burn embrocation for external use

Publications (1)

Publication Number Publication Date
JPS6438023A true JPS6438023A (en) 1989-02-08

Family

ID=18054869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61314570A Pending JPS6438023A (en) 1986-12-23 1986-12-23 Unshakable specific drug for burn embrocation for external use

Country Status (1)

Country Link
JP (1) JPS6438023A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5676975A (en) * 1995-06-29 1997-10-14 Dezes; Alexander C. Burn symptom relief composition and method of producing same
CN107184647A (en) * 2017-06-02 2017-09-22 陈晓纪 A kind of external application of Chinese medicine is dispelled scar cream

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5676975A (en) * 1995-06-29 1997-10-14 Dezes; Alexander C. Burn symptom relief composition and method of producing same
CN107184647A (en) * 2017-06-02 2017-09-22 陈晓纪 A kind of external application of Chinese medicine is dispelled scar cream

Similar Documents

Publication Publication Date Title
FI883423A (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISK ANVAENDBARA PIPERAZINYLDERIVAT AV PURINER.
Horita et al. Pyretogenic effect of lysergic acid diethylamide
DK0614616T3 (en) Preparation for the treatment of patients with liver disease
ATE96807T1 (en) RCRF AND SIMILAR RELATIONS.
SE8300623D0 (en) PHARMACEUTICAL COMPOSITION CONTAINING STABLE MICROCRISTALLIN CIS-PLATINA (II) -DIAMMINE DICHLORIDE (CISPLATIN)
LV10954A (en) Derivatives of benzimidazole as a result of their acquisition and their pharmaceutical composition
NO882615D0 (en) PHARMACEUTICAL PREPARATION WITH FINALLY SHARED EBSELEN CRYSTALS.
KR870700599A (en) Carboxylic acid derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses thereof
ES2108129T3 (en) NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE.
DE3774795D1 (en) PHENOXYACETIC ACID COMPOUNDS, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR USE.
KR870007118A (en) Optically pure compound and preparation method thereof
ES8603258A1 (en) Compositions for cosmetic, health- and body-preserving use
Tennent Factors influencing the effects of alcohol on blood sugar and liver glycogen
JPS6438023A (en) Unshakable specific drug for burn embrocation for external use
ATE62908T1 (en) NEW DERIVATIVES OF 4,5-DIHYDRO-OXAZOLES, PROCESS FOR THEIR PRODUCTION AND THEIR USE.
ATE3552T1 (en) PROCESS FOR THE PREPARATION OF PHOSPHONO-HYDROXY-ACETIC ACID AND SALTS THEREOF AND AUTIVIRALS CONTAINING THEM.
DE3769347D1 (en) INJECTION PREPARATIONS CONTAINING POLYPRENYL ALCOHOL AND THEIR USE.
JPS6456622A (en) Percutaneous absorbefacient base composition
ATE59038T1 (en) TAURINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
HIRATA et al. The right foot joint infection with Mycobacterium nonchromogenicum. A case report
ES2057147T3 (en) CRF OF FISH.
ES2034510T5 (en) DISPERSED CERAMIC MASS.
Rowntree et al. The biological effects of thymus extract (Hanson)
Kirsner et al. Effect of Dialyzed Enterogastrone Upon Twelve-Hour Nocturnal Gastric Secretion in Man.
Char et al. Alteration of Serum Protein Patterns Following Adrenalectomy in Rabbits.